These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 29986763
1. Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review. Kabuyaya M, Chimbari MJ, Mukaratirwa S. Infect Dis Poverty; 2018 Jul 05; 7(1):73. PubMed ID: 29986763 [Abstract] [Full Text] [Related]
2. Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study. Kokaliaris C, Garba A, Matuska M, Bronzan RN, Colley DG, Dorkenoo AM, Ekpo UF, Fleming FM, French MD, Kabore A, Mbonigaba JB, Midzi N, Mwinzi PNM, N'Goran EK, Polo MR, Sacko M, Tchuem Tchuenté LA, Tukahebwa EM, Uvon PA, Yang G, Wiesner L, Zhang Y, Utzinger J, Vounatsou P. Lancet Infect Dis; 2022 Jan 05; 22(1):136-149. PubMed ID: 34863336 [Abstract] [Full Text] [Related]
3. Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa. Ndeffo Mbah ML, Skrip L, Greenhalgh S, Hotez P, Galvani AP. PLoS Negl Trop Dis; 2014 Oct 05; 8(10):e3234. PubMed ID: 25329403 [Abstract] [Full Text] [Related]
5. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon. Tchuem Tchuenté LA, Momo SC, Stothard JR, Rollinson D. Acta Trop; 2013 Nov 05; 128(2):275-83. PubMed ID: 23791803 [Abstract] [Full Text] [Related]
6. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review. King CH, Olbrych SK, Soon M, Singer ME, Carter J, Colley DG. PLoS Negl Trop Dis; 2011 Sep 05; 5(9):e1321. PubMed ID: 21949893 [Abstract] [Full Text] [Related]
7. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium. Coulibaly JT, N'gbesso YK, Knopp S, Keiser J, N'Goran EK, Utzinger J. PLoS Negl Trop Dis; 2012 Sep 05; 6(12):e1917. PubMed ID: 23236526 [Abstract] [Full Text] [Related]
8. Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial. Obonyo CO, Rawago FO, Makworo NK, Muok EMO. Parasit Vectors; 2024 Jun 28; 17(1):279. PubMed ID: 38943214 [Abstract] [Full Text] [Related]
9. Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis. Lai YS, Biedermann P, Ekpo UF, Garba A, Mathieu E, Midzi N, Mwinzi P, N'Goran EK, Raso G, Assaré RK, Sacko M, Schur N, Talla I, Tchuenté LA, Touré S, Winkler MS, Utzinger J, Vounatsou P. Lancet Infect Dis; 2015 Aug 28; 15(8):927-40. PubMed ID: 26004859 [Abstract] [Full Text] [Related]
11. Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials. Zwang J, Olliaro PL. PLoS Negl Trop Dis; 2014 Aug 28; 8(11):e3286. PubMed ID: 25412105 [Abstract] [Full Text] [Related]
12. Prevalence of urogenital and intestinal schistosomiasis among school children in South-west Nigeria. Ojo JA, Adedokun SA, Akindele AA, Olorunfemi AB, Otutu OA, Ojurongbe TA, Thomas BN, Velavan TP, Ojurongbe O. PLoS Negl Trop Dis; 2021 Jul 28; 15(7):e0009628. PubMed ID: 34314428 [Abstract] [Full Text] [Related]
13. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger. Garba A, Lamine MS, Djibo A, Tahirou A, Aouami MA, Alfari A, Phillips AE, Fenwick A, Utzinger J. Acta Trop; 2013 Nov 28; 128(2):318-25. PubMed ID: 23237719 [Abstract] [Full Text] [Related]
14. Differential impact of mass and targeted praziquantel delivery on schistosomiasis control in school-aged children: A systematic review and meta-analysis. Cribb DM, Clarke NE, Doi SAR, Vaz Nery S. PLoS Negl Trop Dis; 2019 Oct 28; 13(10):e0007808. PubMed ID: 31603895 [Abstract] [Full Text] [Related]
15. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya. Gouvras AN, Kariuki C, Koukounari A, Norton AJ, Lange CN, Ireri E, Fenwick A, Mkoji GM, Webster JP. Acta Trop; 2013 Nov 28; 128(2):309-17. PubMed ID: 23313322 [Abstract] [Full Text] [Related]
17. The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment. Koukounari A, Donnelly CA, Sacko M, Keita AD, Landouré A, Dembelé R, Bosqué-Oliva E, Gabrielli AF, Gouvras A, Traoré M, Fenwick A, Webster JP. BMC Infect Dis; 2010 Jul 29; 10():227. PubMed ID: 20670408 [Abstract] [Full Text] [Related]
18. Prevalence and correlations of schistosomiasis mansoni and schistosomiasis haematobium among humans and intermediate snail hosts: a systematic review and meta-analysis. Wang XY, Li Q, Li YL, Guo SY, Li SZ, Zhou XN, Guo JG, Bergquist R, Juma S, Zhang JF, Yang K, Xu J. Infect Dis Poverty; 2024 Sep 02; 13(1):63. PubMed ID: 39218903 [Abstract] [Full Text] [Related]
19. Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis. Zwang J, Olliaro P. Parasit Vectors; 2017 Jan 26; 10(1):47. PubMed ID: 28126024 [Abstract] [Full Text] [Related]
20. Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial. Coulibaly JT, Panic G, Yapi RB, Kovač J, Barda B, N'Gbesso YK, Hattendorf J, Keiser J. BMC Med; 2018 Jun 01; 16(1):81. PubMed ID: 29855373 [Abstract] [Full Text] [Related] Page: [Next] [New Search]